$216 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 58 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 34.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VRTX | Sell | Vertex Pharmaceuticals Inc | $14,232,000 | -8.7% | 84,022 | -1.2% | 6.58% | +13.8% |
| NBIX | Sell | Neurocrine Biosciences Inc | $13,266,000 | +0.2% | 147,300 | -6.1% | 6.13% | +24.9% |
| PTCT | Sell | PTC Therapuetics COM | $7,982,000 | -31.4% | 236,000 | -8.9% | 3.69% | -14.5% |
| BIIB | Sell | Biogen Inc | $7,381,000 | -26.1% | 31,700 | -25.8% | 3.41% | -7.9% |
| IONS | Sell | Ionis Pharmaceuticals Inc | $2,767,000 | -48.0% | 46,181 | -44.2% | 1.28% | -35.2% |
| SAGE | Sell | Sage Therapeutics Inc | $2,245,000 | -63.9% | 16,000 | -52.9% | 1.04% | -55.1% |
| KALV | Sell | Kalvista Pharmaceuticals Inc | $2,058,000 | -50.6% | 177,433 | -5.4% | 0.95% | -38.4% |
| EXEL | Sell | Exelixis Inc | $1,830,000 | -80.7% | 103,534 | -76.7% | 0.85% | -75.9% |
| ASND | Sell | Ascendis Pharma ASsponsored adr | $1,329,000 | -55.2% | 13,800 | -46.5% | 0.61% | -44.2% |
| STRO | Sell | SUTRO BIOPHARMA INC | $1,264,000 | -23.0% | 139,331 | -4.0% | 0.58% | -4.1% |
| GBT | Sell | Global Blood Therapeutics | $897,000 | -39.1% | 18,500 | -33.9% | 0.42% | -24.0% |
| HALO | Sell | Halozyme Therapeutics Inc | $816,000 | -90.0% | 52,633 | -88.9% | 0.38% | -87.5% |
| MYGN | Sell | Myriad Genetics inc | $716,000 | -35.6% | 25,000 | -37.5% | 0.33% | -19.7% |
| ARQL | Sell | Arqule INC | $294,000 | -88.8% | 41,000 | -82.9% | 0.14% | -86.1% |
| GTHX | Sell | G1 Therapeutics Inc | $255,000 | -94.3% | 11,200 | -92.3% | 0.12% | -92.9% |
| RTRX | Exit | Retrophin Inc | $0 | – | -18,000 | -100.0% | -0.13% | – |
| PRQR | Exit | PROQR therapeutics N V | $0 | – | -56,000 | -100.0% | -0.19% | – |
| LGND | Exit | Ligand Pharmaceuticals Inc | $0 | – | -7,300 | -100.0% | -0.31% | – |
| CNCE | Exit | CONCERT PHARMACEUTICALS INC | $0 | – | -70,000 | -100.0% | -0.31% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -70,000 | -100.0% | -0.59% | – |
| XENT | Exit | Intersect Ent Inc | $0 | – | -96,000 | -100.0% | -0.81% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -50,949 | -100.0% | -0.83% | – |
| IOVA | Exit | Iovance Biotherapeutics INC | $0 | – | -104,000 | -100.0% | -0.94% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.